このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Dr. Reddy's Laboratories バランスシートの健全性
財務の健全性 基準チェック /66
Dr. Reddy's Laboratoriesの総株主資本は₹280.6B 、総負債は₹14.0Bで、負債比率は5%となります。総資産と総負債はそれぞれ₹387.5Bと₹107.0Bです。 Dr. Reddy's Laboratoriesの EBIT は₹66.2Bで、利息カバレッジ比率-16.6です。現金および短期投資は₹81.5Bです。
主要情報
5.9%
負債資本比率
₹16.52b
負債
| インタレスト・カバレッジ・レシオ | -115.2x |
| 現金 | ₹81.47b |
| エクイティ | ₹280.55b |
| 負債合計 | ₹106.97b |
| 総資産 | ₹387.52b |
財務の健全性に関する最新情報
Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21
Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?
Sep 28Recent updates
Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05Is Dr. Reddy's Laboratories (NSE:DRREDDY) A Risky Investment?
Sep 28Do Dr. Reddy's Laboratories' (NSE:DRREDDY) Earnings Warrant Your Attention?
Aug 17Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Shares Could Be 33% Above Their Intrinsic Value Estimate
Jul 21Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹30.00
Jul 08財務状況分析
短期負債: DRREDDYの 短期資産 ( ₹248.0B ) が 短期負債 ( ₹96.0B ) を超えています。
長期負債: DRREDDYの短期資産 ( ₹248.0B ) が 長期負債 ( ₹10.9B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: DRREDDY総負債よりも多くの現金を保有しています。
負債の削減: DRREDDYの負債対資本比率は、過去 5 年間で26.9%から5%に減少しました。
債務返済能力: DRREDDYの負債は 営業キャッシュフロー によって 十分にカバー されています ( 323.8% )。
インタレストカバレッジ: DRREDDY支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。